Clinical Trials Arena December 1, 2023
Robert Barrie

The app will scan users’ faces and analyse voices to detect and monitor depression in women at different stages of pregnancy.

The Medical and Healthcare products Regulatory Agency (MHRA) has greenlit BlueSkeye AI to begin a clinical trial investigating its TrueBlue mental health app for women at various stages of pregnancy.

The trial, which is being conducted in partnership with the UK’s Institute of Mental Health, will establish the safety and efficacy of the app. It is slated to enrol 125 perinatal women through NHS hospitals and will begin in early 2024, lasting for 14 months, according to a 30 November press release.

BlueSkeye AI’s app uses artificial intelligence (AI) to scan the user’s face and analyse their voice to...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Apps, Clinical Trials, Mental Health, Provider, Technology, Trends
CIOs Are Adjusting to a New Job Description
New AI Tool Boosts Detection of Airway Nodules
To Deliver Meaningful Business Value, AI Must Grasp Context
How to bring AI to community hospitals
Healthcare AI newswatch: Ambient AI costs, healthcare AI holdouts, an 86-year-old AI innovator, more

Share This Article